Jiandong Su

4.5k total citations
130 papers, 2.9k citations indexed

About

Jiandong Su is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Jiandong Su has authored 130 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Rheumatology, 50 papers in Immunology and 17 papers in Molecular Biology. Recurrent topics in Jiandong Su's work include Systemic Lupus Erythematosus Research (96 papers), Atherosclerosis and Cardiovascular Diseases (37 papers) and Monoclonal and Polyclonal Antibodies Research (17 papers). Jiandong Su is often cited by papers focused on Systemic Lupus Erythematosus Research (96 papers), Atherosclerosis and Cardiovascular Diseases (37 papers) and Monoclonal and Polyclonal Antibodies Research (17 papers). Jiandong Su collaborates with scholars based in Canada, United States and China. Jiandong Su's co-authors include Dafna D. Gladman, Murray B. Urowitz, Zahi Touma, Konstantinos Tselios, Paul R. Fortin, Wendy Lou, Nicole Anderson, Charmaine E. Lok, Matthew J. Oliver and Cynthia Bhola and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jiandong Su

123 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiandong Su Canada	31	2.0k	1.0k	437	382	372	130	2.9k
Emília Inoue Sato Brazil	33	2.0k 1.0×	1.0k 1.0×	453 1.0×	689 1.8×	364 1.0×	125	3.2k
Lene Dreyer Denmark	37	2.6k 1.3×	1.3k 1.3×	363 0.8×	500 1.3×	202 0.5×	172	4.4k
Denis Wahl France	36	2.3k 1.1×	440 0.4×	340 0.8×	362 0.9×	408 1.1×	135	4.2k
Inmaculada del Rincón United States	26	2.7k 1.4×	773 0.7×	437 1.0×	344 0.9×	272 0.7×	45	3.8k
Zahi Touma Canada	33	3.1k 1.6×	2.0k 1.9×	209 0.5×	541 1.4×	762 2.0×	186	4.1k
Agustín Escalante United States	28	3.0k 1.5×	1.1k 1.0×	377 0.9×	335 0.9×	350 0.9×	61	4.4k
Lisa R. Sammaritano United States	37	4.4k 2.2×	2.4k 2.3×	339 0.8×	491 1.3×	500 1.3×	88	5.7k
Wietske Kievit Netherlands	38	1.7k 0.8×	1.1k 1.1×	317 0.7×	585 1.5×	204 0.5×	171	4.1k
Bryant R. England United States	27	1.5k 0.8×	389 0.4×	664 1.5×	348 0.9×	125 0.3×	129	2.8k
Candace H. Feldman United States	25	1.7k 0.8×	756 0.7×	139 0.3×	276 0.7×	173 0.5×	102	2.5k

Countries citing papers authored by Jiandong Su

Since Specialization

Citations

This map shows the geographic impact of Jiandong Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiandong Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiandong Su more than expected).

Fields of papers citing papers by Jiandong Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiandong Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiandong Su. The network helps show where Jiandong Su may publish in the future.

Co-authorship network of co-authors of Jiandong Su

This figure shows the co-authorship network connecting the top 25 collaborators of Jiandong Su. A scholar is included among the top collaborators of Jiandong Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiandong Su. Jiandong Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Wei, et al.. (2025). Progress of microneedle targeted modulation technology in the reconstruction of immune microenvironment in diabetic wounds. European journal of medical research. 30(1). 405–405.

Muñoz‐Grajales, Carolina, Juan Pablo Díaz-Martínez, Jiandong Su, et al.. (2025). Association of Elevated Serum S100A8 / A9 Levels and Cognitive Impairment in Patients With Systemic Lupus Erythematosus. Arthritis Care & Research. 77(11). 1303–1312.

Venner, Christopher P., Peter Duggan, Kevin Song, et al.. (2024). Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group Database. Transplantation and Cellular Therapy. 30(9). 889–901. 1 indexed citations

Zhang, Yong, et al.. (2024). Epidemiological and clinical characteristics of severe burns in adults: A retrospective study at a burn centre in Suzhou, China. International Wound Journal. 21(12). e70097–e70097.

McCurdy, Arleigh, Donna Reece, Martha Louzada, et al.. (2024). Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed/refractory relapsed multiple myeloma: a subgroup analysis of the ALGONQUIN trial. Blood Cancer Journal. 14(1). 155–155. 2 indexed citations

Almaghlouth, Ibrahim, Wael Alqarawi, Kazi Nur Asfina, et al.. (2024). Prevalence of major adverse cardiovascular events among Saudi patients with systemic lupus erythematosus compared with the general population: updates from the national SLE and PURE cohorts. Lupus Science & Medicine. 11(1). e001158–e001158. 1 indexed citations

Zhang, Yong, et al.. (2024). Epidemiological and clinical characteristics of burns in adults: a 6-year retrospective study in a major burn center in Suzhou, China. Frontiers in Public Health. 12. 1413986–1413986. 1 indexed citations

Feld, Joy, Oshrat E Tayer-Shifman, Jiandong Su, Melanie Anderson, & Zahi Touma. (2024). Primary headache in SLE –systematic review and meta-analysis. Seminars in Arthritis and Rheumatism. 69. 152566–152566. 2 indexed citations

Su, Jiandong, Kathleen Bingham, Lesley Ruttan, et al.. (2023). Centrally acting ACE inhibitor (cACEi) and angiotensin receptor blocker (cARB) use and cognitive dysfunction in patients with SLE. Lupus Science & Medicine. 10(2). e000923–e000923. 5 indexed citations

10.

McCurdy, Arleigh, Donna Reece, Christopher P. Venner, et al.. (2023). Second Line Treatment and Outcomes of Patients with Multiple Myeloma: A Real World Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database. Blood. 142(Supplement 1). 3364–3364. 1 indexed citations

11.

Knight, Andrea, Kathleen Bingham, Jiandong Su, et al.. (2023). In-person versus virtual administration of the American College of Rheumatology gold standard cognitive battery in systemic lupus erythematosus: Are they interchangeable?. Lupus. 32(6). 737–745. 2 indexed citations

12.

Jiang, Chenyu, Wei Cheng, Kai Yang, et al.. (2023). A solid strategy to realize efficient antibacterial activity on the shade surface of bulk silicon under natural or indoor lighting. Chemical Engineering Journal. 479. 147734–147734. 3 indexed citations

13.

Tayer-Shifman, Oshrat E, Robin Green, Patricia Katz, et al.. (2022). Assessing the Utility of the Montreal Cognitive Assessment in Screening for Cognitive Impairment in Patients With Systemic Lupus Erythematosus. Arthritis Care & Research. 75(3). 569–577. 12 indexed citations

14.

Gladman, Dafna D., et al.. (2022). The new EULAR/ACR 2019 SLE classification criteria: A predictor of long-term outcomes. Seminars in Arthritis and Rheumatism. 57. 152103–152103. 5 indexed citations

15.

Beaton, Dorcas, Kathleen Bingham, Patricia Katz, et al.. (2021). Validation of the automated neuropsychological assessment metrics for assessing cognitive impairment in systemic lupus erythematosus. Lupus. 31(1). 45–54. 8 indexed citations

16.

Tselios, Konstantinos, Dafna D. Gladman, Jiandong Su, & Murray B. Urowitz. (2020). Advanced Chronic Kidney Disease in Lupus Nephritis: Is Dialysis Inevitable?. The Journal of Rheumatology. 47(9). 1366–1373. 11 indexed citations

17.

Tselios, Konstantinos, Dafna D. Gladman, Paula J. Harvey, et al.. (2018). Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials?. The Journal of Rheumatology. 46(1). 64–69. 16 indexed citations

18.

Gladman, Dafna D., et al.. (2017). Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritis. Lupus. 27(3). 468–474. 30 indexed citations

19.

Su, Jiandong, et al.. (2016). [Probability of premature mortality caused by non-communicable diseases in Beijing, 2010-2015].. PubMed. 37(9). 1268–1271. 2 indexed citations

20.

To, Teresa, Laura Y. Feldman, Jacqueline Simatovic, et al.. (2015). Health risk of air pollution on people living with major chronic diseases: a Canadian population-based study. BMJ Open. 5(9). e009075–e009075. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact